Analysis-Novo Nordisk changes tack with bold raid on Pfizer obesity deal
By Maggie Fick LONDON (Reuters) -Novo Nordisk’s late bid to hijack Pfizer’s takeover of U.S. obesity biotech Metsera marks an…
By Maggie Fick LONDON (Reuters) -Novo Nordisk’s late bid to hijack Pfizer’s takeover of U.S. obesity biotech Metsera marks an…